Differential patterns of dopamine transporter loss in the basal ganglia of progressive supranuclear palsy and Parkinson's disease:: Analysis with [123I]IPT single photon emission computed tomography

被引:30
|
作者
Im, Joo-Hyuk
Chung, Sun J.
Kim, Jae-Seung
Lee, Myoung C.
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul 138736, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Nucl Med, Seoul 138736, South Korea
关键词
Parkinson's disease; progressive supranuclear palsy; dopamine transporter; single photon emission tomography; striatum; substantia nigra;
D O I
10.1016/j.jns.2006.01.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We evaluated the patterns of dopamine transporter loss in the striatum of ten controls, twenty patients with Parkinson's disease (PD), and nine with progressive supranuclear palsy (PSP) using I-123-IPT single photon emission tomography (SPECT). Four ROIs in the striatum correspond to the head of caudate nucleus (ROI 1), a transitional region between head of caudate and putamen (ROI 2), anterior putamen (ROI 3), and posterior putamen (ROI 4). A striatal ratio of specific to nondisplaceable uptake (V3") was calculated normalizing the activity of the ROIs to that of occipital cortex. V3" values were significantly reduced in all ROIs of PD and PSP patients, compared with controls (p=0.001). V3" value in ROI 2 was significantly lower in PSP group, compared with PD group (p=0.02). The percent reductions of striatal uptake in ROI 1, ROI 2, ROI 3 and ROI 4 were 56%, 53%, 64% and 78% in PD patients, whereas 75%, 72%, 75% and 77% in PSP patients, respectively. The reduction patterns of uptake were significantly different between PD and PSP groups (p=0.001). In PD patients, the percent reductions of I-123-IPT uptake were significantly greater in ROI 3 and 4 compared with ROI I or 2, whereas those were similar in all ROIs of PSP patients. In addition, PD patients showed a significantly higher posterior putamen/caudate ratio of reduced I-123-IPT uptake than the anterior putamen/caudate ratio (p=0.005). Our results implicate that I-123-IPT SPECT is a relatively simple and reliable technique that may be useful in differentiating PD from PSP. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:103 / 109
页数:7
相关论文
共 50 条
  • [1] Differential patterns of dopamine transporter loss in the basal ganglia of Progressive Supranuclear Palsy and Parkinson's disease:: Analysis with [123I]IPT single photon emission computed tomography
    Im, JH
    Kim, JS
    Lee, MC
    MOVEMENT DISORDERS, 2002, 17 : S171 - S172
  • [2] Differential distribution of striatal [123I]β-CIT in Parkinson’s disease and progressive supranuclear palsy, evaluated with single-photon emission tomography
    C. Messa
    M. A. Volonté
    F. Fazio
    F. Zito
    A. Carpinelli
    A. d’Amico
    G. Rizzo
    R. M. Moresco
    E. Paulesu
    M. Franceschi
    G. Lucignani
    European Journal of Nuclear Medicine, 1998, 25 : 1270 - 1276
  • [3] Comparison of striatal dopamine D2 receptors in Parkinson's disease and progressive supranuclear palsy patients using [123I] iodobenzofuran single-photon emission computed tomography
    Oyanagi, C
    Katsumi, Y
    Hanakawa, T
    Hayashi, T
    Thuy, DHD
    Hashikawa, K
    Nagahama, Y
    Fukuyama, H
    Shibasaki, H
    JOURNAL OF NEUROIMAGING, 2002, 12 (04) : 316 - 324
  • [4] Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography
    Klaus Tatsch
    Johannes Schwarz
    P. David Mozley
    Rainer Linke
    Oliver Pogarell
    Wolfgang H. Oertel
    Ruth S. Fieber
    Klaus Hahn
    Hank F. Kung
    European Journal of Nuclear Medicine, 1997, 24 : 415 - 421
  • [5] Topography of dopamine transporter availability in progressive supranuclear palsy -: A voxelwise [123I]β-CIT SPECT analysis
    Seppi, Klaus
    Scherfler, Christoph
    Donnemiller, Eveline
    Virgolini, Irene
    Schocke, Michael F. H.
    Goebel, Georg
    Mair, Katherina J.
    Boesch, Sylvia
    Brenneis, Christian
    Wenning, Gregor K.
    Poewe, Werner
    ARCHIVES OF NEUROLOGY, 2006, 63 (08) : 1154 - 1160
  • [6] Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease -: Implications for a preclinical diagnosis
    Schwarz, J
    Linke, R
    Kerner, M
    Mozley, PD
    Trenkwalder, C
    Gasser, T
    Tatsch, K
    ARCHIVES OF NEUROLOGY, 2000, 57 (02) : 205 - 208
  • [7] Differential distribution of striatal [123l]β-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography
    Messa, C.
    Volonté, M.A.
    Fazio, F.
    Zito, F.
    Carpinelli, A.
    D'Amico, A.
    Rizzo, G.
    Moresco, R.M.
    Paulesu, E.
    Franceschi, M.
    Lucignani, G.
    European Journal of Nuclear Medicine and Molecular Imaging, 1998, 25 (09): : 1270 - 1276
  • [8] Differential distribution of striatal [123l]β-CIT in Parkinson's disease and progressive supranuclear palsy, evaluated with single-photon emission tomography
    Messa, C
    Volonté, MA
    Fazio, F
    Zito, F
    Carpinelli, A
    d'Amico, A
    Rizzo, G
    Moresco, RM
    Paulesu, E
    Franceschi, M
    Lucignani, G
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1998, 25 (09) : 1270 - 1276
  • [9] Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [I-123]IPT and single-photon emission tomography
    Tatsch, K
    Schwarz, J
    Mozley, PD
    Linke, R
    Pogarell, O
    Oertel, WH
    Fieber, RS
    Hahn, K
    Kung, HF
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1997, 24 (04) : 415 - 421
  • [10] Correlative single photon emission computed tomography imaging of [123I]altropane binding in the rat model of Parkinson's
    Gleave, Jacqueline A.
    Farncombe, Troy H.
    Saab, Chantal
    Doering, Laurie C.
    NUCLEAR MEDICINE AND BIOLOGY, 2011, 38 (05) : 741 - 749